A study by Haure-Mirande et al. proposed that the absence of TYROBP in a mouse model of AD-type cerebral Aβ amyloidosis (APP/PSEN1 mouse model) protected against the dysregulation of complement transcriptomic network during AD pathogenesis [154]. Here, TYROBP is linked to Alzheimer disease.